Chemical Compound

199327-61-2

CAS Registry Number 199327-61-2
199327-61-2 chemical structure
Primary Record

199327-61-2

In stock
9,284 g
Purity
99.4 %
CAS
199327-61-2

Compound Identifiers & Properties

CAS
199327-61-2
PubChem CID
135399673
SMILES
COC1=C(C=C2C(=C1)N=CNC2=O)OCCCN3CCOCC3
Canonical SMILES
COc1cc2nc[nH]c(=O)c2cc1OCCCN1CCOCC1

Names & Synonyms

  • 199327-61-2
  • Gefitinib Impurity 5
  • Morfon
  • 7-Methoxy-6-(3-morpholin-4-ylpropoxy)quinazolin-4(3H)-one
  • 7-methoxy-6-(3-morpholinopropoxy)quinazolin-4(3H)-one
  • Gefitinib Impurity 12
  • Gefitinib Impurity C
  • Gefitinib Impurity 3
  • Gefitinib EP Impurity A
  • intermediate of gefitinib
  • MFCD12760130
  • RefChem:546718
  • R9YH59H93M
  • WFUBWLXSYCFZEH-UHFFFAOYSA-N
  • C16H21N3O4
  • UNII-R9YH59H93M
  • SCHEMBL829762
  • SCHEMBL25281864
  • SCHEMBL28431957
  • SCHEMBL29478512
  • SCHEMBL29478513
  • CTK0H3924
  • DTXSID90439401
  • BCP26350
  • KS-00000I4Z
  • Gefitinib related compound A [USP]
  • ANW-23857
  • ZINC22062324
  • 7-Methoxy-6-(3-morpholin-4-yl-propoxy)-3H-quinazolin-4-one
  • AKOS015917892
  • AKOS025401601
  • ACN-028885
  • DS-1851
  • FD16024
  • RL02495
  • 5alpha-Androstan-17beta-ol-3,7-dione
  • CID10403660
  • EC 429-400-7
  • AC-22622
  • AJ-80907
  • AK-47996
  • AN-30109
  • SC-72020
  • SY039369
  • 7-Methoxy-6-(3-morpholinopropoxy)quinazolin-4(1h)-one
  • 4(3H)-Quinazolinone, 7-methoxy-6-[3-(4-morpholinyl)propoxy]-
  • AB0000528
  • DB-066001
  • HY-133779
  • ST2406577
  • 4CH-017695
  • 7-methoxy-6-(3-morpholin-4-ylpropoxy)-1H-quinazolin-4-one
  • AM20090617
  • CS-0131955
  • FT-0660445
  • NS00077739
  • X2633
  • 7-Methoxy-6-[3-(4-morpholinyl)propoxy]-4(3H)-quinazolinone
  • J1.646.599B
  • 7-Methoxy-6-(3-morpholinopropoxy)-quinazolin-4(3H)-one
  • A18404
  • S-0018
  • 327M612
  • 4(1H)-Quinazolinone, 7-methoxy-6-[3-(4-morpholinyl)propoxy]-
  • 7-methoxy-6-(3-morpholinopropoxy)-1H-quinazolin-4-one
  • 7-Methoxy-6-(3-morpholinopropoxy)-3,4-dihydroquinazolin-4-one
  • 7-Methoxy-6-[3-(morpholin-4-yl)propoxy]quinazolin-4(3H)-one
  • F793847
  • I14-8804
  • 7-Methoxy-6-(3-morpholin-4-yl-propoxy)-3H-quinazol
  • 6-(3-Morpholinopropoxy)-7-methoxyquinazoline-4(3H)-one
  • 7-Methoxy-6-(3-morpholinopropoxy)-4(3H)-quinazolinone
  • 7-Methoxy-6-(3-morpholinopropoxy)quinazoline-4(3H)-one
  • 7-Methoxy-6-(3-morpholinopropyloxy)quinazoline-4(3H)-one
  • 7-methoxy-6-[3-(morpholin-4-yl)propoxy]-3,4-dihydroquinazolin-4-one
  • 199327-61-2(N-2)
  • 4(3H)-Quinazolinone,7-methoxy-6-[3-(4-morpholinyl)propoxy]-
  • 7-Methoxy-6-(3-(4-morpholinyl)propoxy)-4(3H)-quinazolinone
  • 7-methoxy-6-(3-morpholin-4-ylpropoxy)-3H-quinazolin-4-one
  • 7-methoxy-6-(3-morpholinopropoxy)-3,4-dihydroquinazolin4-one
  • 7-Methoxy-6-[3-(4-morpholinyl)propoxy]-4(1H)-quinazolinone
  • 7-Methoxy-6-[3-(morpholin-4-yl)propoxy]quinazolin-4(1H)-one
  • 7-methoxy-6-[3-(morpholin-4-yl)propoxy]-1,4-dihydroquinazolin-4-one
  • 7-METHOXY-6-[3-(MORPHOLIN-4-YL)PROPOXY]-3H-QUINAZOLIN-4-ONE
  • 4(3H)-Quinazolinone, 7-methoxy-6-[3-(4-morpholinyl)propoxy]-; 4(1H)-Quinazolinone, 7-methoxy-6-[3-(4-morpholinyl)propoxy]- (9CI); 7-Methoxy-6-[3-(4-morpholinyl)propoxy]-4(3H)-quinazolinone; 7-Methoxy-6-(3-(morpholin-4-yl)propoxy)-3H-quinazolin-4-one; 7-Methoxy-6-(3-morpholinopropoxy)-3,4-dihydroquinazolin-4-one; 7-Methoxy-6-[3-(4-morpholinyl)propoxy]quinazolin-4(3H)-one; Gefitinib Imp. A (EP); Gefitinib Impurity A
  • 429-400-7
  • 7-methoxy-6-(3-morpholin-4-yl-propoxy)-3H-quinazolin-4-one;[containing < 0.5 % formamide (EC No 200-842-0)]7-methoxy-6-(3-morpholin-4-yl-propoxy)-3H-quinazolin-4-one; [containing >= 0.5 % formamide (EC No 200-842-0)]